General MedicationsINTRAVENOUSGeneric
ESOMEPRAZOLE SODIUM
ESOMEPRAZOLE SODIUM
Standard Dose
EQ 20MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ESOMEPRAZOLE SODIUM is listed in Drugs@FDA under application 204657 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ESOMEPRAZOLE SODIUM Form and strength INJECTABLE;INTRAVENOUS - EQ 20MG BASE/VIAL Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-02-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview ESOMEPRAZOLE SODIUM is listed in Drugs@FDA under application 204657 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ESOMEPRAZOLE SODIUM Form and strength INJECTABLE;INTRAVENOUS - EQ 20MG BASE/VIAL Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-02-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.